Compare IMXI & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMXI | TMCI |
|---|---|---|
| Founded | 1994 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 456.2M | 401.8M |
| IPO Year | N/A | 2021 |
| Metric | IMXI | TMCI |
|---|---|---|
| Price | $15.40 | $2.74 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 6 |
| Target Price | ★ $16.67 | $7.07 |
| AVG Volume (30 Days) | 241.2K | ★ 1.3M |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.29 | N/A |
| Revenue | ★ $625,123,000.00 | $218,879,000.00 |
| Revenue This Year | N/A | $3.25 |
| Revenue Next Year | $0.95 | $1.07 |
| P/E Ratio | $11.94 | ★ N/A |
| Revenue Growth | N/A | ★ 7.90 |
| 52 Week Low | $8.58 | $2.56 |
| 52 Week High | $22.30 | $10.79 |
| Indicator | IMXI | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 76.84 | 24.19 |
| Support Level | $15.06 | $2.64 |
| Resistance Level | $15.36 | $3.15 |
| Average True Range (ATR) | 0.07 | 0.21 |
| MACD | 0.01 | 0.09 |
| Stochastic Oscillator | 100.00 | 31.83 |
International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.